Accession Number: | 0001628280-21-017225 |
Date: | 2021-08-16 |
Issuer: | BELLICUM PHARMACEUTICALS, INC (BLCM) |
Original Submission Date: | 2021-08-16 |
FAIR RICHARD A.
C/O BELLICUM PHARMACEUTICALS, INC.
3730 KIRBY DRIVE, SUITE 1200
HOUSTON, TX 77098
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.88 | 2021-08-16 | deemed execution date | A | 265,000 (a) | 2022-08-16 | 2031-08-16 | common stock 265,000 | $2.88 | 265,000 | direct |
ID | footnote |
---|---|
f1 | this amendment is being filed to correct the typographical error in the exercise price of the stock option on the original form 4 filed with the sec on august 16, 2021 |